Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.07), versus $0.05 reported last year. Revenue for the quarter came in at $59.71 million, versus $59.32 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.